ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Weight Management & Chronic Illness

Japanese green tea consumers have reduced risk of dementia

Meet the ProHealth Editors

Do Nothing, Accomplish Everything! The Connection Between Breathing and Healing

Best Herbs to Help With Insomnia

Choline: Why You Should Eat Your Egg Yolks and Take Krill

Calcium, vitamin D supplementation associated improved stroke recovery

Acupressure reduced fatigue in breast cancer survivors

Fight Back! Win the War Being Waged Against Your Immune System

More positive evidence for melatonin in breast cancer battle

 
Print Page
Email Article

AMARIN CORPORATION ANNOUNCES ZELAPAR™ RECEIVES APPROVABLE LETTER FROM FDA [Parkinson's News]

  [ 42 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 19, 2003


London, United Kingdom, February 18, 2003-- Amarin Corporation plc (NASDAQ: AMRN) announced today that Zelapar™ (selegiline HCl orally disintegrating tablets) has received an approvable letter from the U.S. Food and Drug Administration (FDA) for a New Drug Application (NDA) filed by a subsidiary of Elan Corporation plc (NYSE: ELN). The FDA accepted the NDA for filing in April 2002.

"We look forward to the remaining requirements of the FDA being expeditiously fulfilled," commented Rick Stewart, Amarin's Chief Executive. "Upon exercise of our option, Zelapar will complement our currently marketed Parkinson's disease product, Permax® (pergolide mesylate) tablets, progressing Amarin toward its stated goal of becoming a leader in the treatment of movement disorders."

Amarin has the exclusive option to acquire the U.S. rights to Zelapar from Elan. Zelapar, a novel and proprietary formulation of selegiline, is an MAO-B inhibitor that addresses the dopamine deficiency, which characterizes Parkinson's disease. Zelapar is an oral tablet using the patented Zydis® fast-dissolving technology of RP Scherer Corporation, a unit of Cardinal Health, Elan's licensor. Zelapar is being developed as an adjunct treatment to levodopa for the symptoms of Parkinson's disease. Selegiline, the active ingredient in Zelapar, is approved for this indication in a conventional tablet form. The Zelapar tablet dissolves in seconds and is absorbed in the tissues of the mouth. There is no need to swallow or use liquid in conjunction with this dosage.

Amarin will hold a conference call to discuss its 2002 annual earnings report later this month, and will provide specific details for the call in a forthcoming release. The approval and launch of a generic to Permax, Amarin's dopamine agonist for the treatment of Parkinson's disease, has resulted in a requirement to review the intangible asset value of Permax. It is expected that a substantial non-cash, exceptional charge will be taken. The final amount will be provided in Amarin's full year 2002 earnings report, to be released later this month.

About Amarin

Amarin Corporation, plc (NASDAQ: AMRN) is a specialty pharmaceutical company focused on neurology and pain management. Amarin has multiple pharmaceutical products on the US market along with a development pipeline that includes two late-stage candidates: Zelapar (selegiline HCl orally disintegrating tablets) for Parkinson's disease and LAX-101, a proprietary compound for Huntington's Disease. For press releases and other Company information, visit our websites at www.amarincorp.com and www.amarinpharma.com.



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Energy NADH™ 12.5mg Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
Coconut Oil - Healthy Gifts from the 'Tree of Life' Coconut Oil - Healthy Gifts from the 'Tree of Life'
Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera
How Glutathione Can Save Your Life How Glutathione Can Save Your Life

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map